nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—Neutropenic infection—Docetaxel—head and neck cancer	0.0755	0.0845	CcSEcCtD
Dexrazoxane—Cardiotoxicity—Fluorouracil—head and neck cancer	0.032	0.0358	CcSEcCtD
Dexrazoxane—Myelosuppression—Vinblastine—head and neck cancer	0.0245	0.0274	CcSEcCtD
Dexrazoxane—Cardiotoxicity—Docetaxel—head and neck cancer	0.0231	0.0258	CcSEcCtD
Dexrazoxane—Myelosuppression—Hydroxyurea—head and neck cancer	0.0223	0.025	CcSEcCtD
Dexrazoxane—Platelet count decreased—Hydroxyurea—head and neck cancer	0.0176	0.0197	CcSEcCtD
Dexrazoxane—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.0174	0.0195	CcSEcCtD
Dexrazoxane—Myelosuppression—Fluorouracil—head and neck cancer	0.0161	0.018	CcSEcCtD
Dexrazoxane—TOP2B—hair follicle—head and neck cancer	0.0156	0.223	CbGeAlD
Dexrazoxane—Neurotoxicity—Docetaxel—head and neck cancer	0.014	0.0157	CcSEcCtD
Dexrazoxane—Sensory loss—Vinblastine—head and neck cancer	0.0132	0.0148	CcSEcCtD
Dexrazoxane—Extravasation—Vinblastine—head and neck cancer	0.0132	0.0147	CcSEcCtD
Dexrazoxane—Febrile neutropenia—Fluorouracil—head and neck cancer	0.0125	0.014	CcSEcCtD
Dexrazoxane—TOP2A—Vindesine—Vinblastine—head and neck cancer	0.0117	0.317	CbGdCrCtD
Dexrazoxane—Myelosuppression—Docetaxel—head and neck cancer	0.0116	0.013	CcSEcCtD
Dexrazoxane—TOP2A—Paclitaxel—Docetaxel—head and neck cancer	0.0114	0.311	CbGdCrCtD
Dexrazoxane—Creatinine increased—Hydroxyurea—head and neck cancer	0.011	0.0123	CcSEcCtD
Dexrazoxane—Phlebitis—Vinblastine—head and neck cancer	0.00967	0.0108	CcSEcCtD
Dexrazoxane—Febrile neutropenia—Docetaxel—head and neck cancer	0.00904	0.0101	CcSEcCtD
Dexrazoxane—Sensory loss—Fluorouracil—head and neck cancer	0.00869	0.00973	CcSEcCtD
Dexrazoxane—Extravasation—Fluorouracil—head and neck cancer	0.00863	0.00966	CcSEcCtD
Dexrazoxane—TOP2B—parotid gland—head and neck cancer	0.00852	0.122	CbGeAlD
Dexrazoxane—TOP2B—saliva-secreting gland—head and neck cancer	0.00816	0.117	CbGeAlD
Dexrazoxane—Haemoglobin decreased—Docetaxel—head and neck cancer	0.0079	0.00884	CcSEcCtD
Dexrazoxane—TOP2B—connective tissue—head and neck cancer	0.0075	0.107	CbGeAlD
Dexrazoxane—TOP2A—Vinorelbine—Vinblastine—head and neck cancer	0.00736	0.2	CbGdCrCtD
Dexrazoxane—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00712	0.00797	CcSEcCtD
Dexrazoxane—Oesophagitis—Fluorouracil—head and neck cancer	0.00688	0.00771	CcSEcCtD
Dexrazoxane—Breast disorder—Hydroxyurea—head and neck cancer	0.00686	0.00768	CcSEcCtD
Dexrazoxane—Pancytopenia—Vinblastine—head and neck cancer	0.00684	0.00765	CcSEcCtD
Dexrazoxane—Sepsis—Fluorouracil—head and neck cancer	0.00654	0.00732	CcSEcCtD
Dexrazoxane—Depression—Vinblastine—head and neck cancer	0.0064	0.00717	CcSEcCtD
Dexrazoxane—TOP2B—trachea—head and neck cancer	0.0063	0.09	CbGeAlD
Dexrazoxane—TOP2A—Vincristine—Vinblastine—head and neck cancer	0.00629	0.171	CbGdCrCtD
Dexrazoxane—Pancytopenia—Hydroxyurea—head and neck cancer	0.00623	0.00698	CcSEcCtD
Dexrazoxane—Extravasation—Docetaxel—head and neck cancer	0.00623	0.00698	CcSEcCtD
Dexrazoxane—Neutropenia—Hydroxyurea—head and neck cancer	0.00614	0.00687	CcSEcCtD
Dexrazoxane—Agranulocytosis—Vinblastine—head and neck cancer	0.00599	0.00671	CcSEcCtD
Dexrazoxane—Infestation—Hydroxyurea—head and neck cancer	0.00585	0.00655	CcSEcCtD
Dexrazoxane—Infestation NOS—Hydroxyurea—head and neck cancer	0.00585	0.00655	CcSEcCtD
Dexrazoxane—Haemoglobin—Vinblastine—head and neck cancer	0.00579	0.00648	CcSEcCtD
Dexrazoxane—Haemorrhage—Vinblastine—head and neck cancer	0.00576	0.00645	CcSEcCtD
Dexrazoxane—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00575	0.00643	CcSEcCtD
Dexrazoxane—Stomatitis—Hydroxyurea—head and neck cancer	0.00571	0.00639	CcSEcCtD
Dexrazoxane—TOP2B—lymphoid tissue—head and neck cancer	0.00548	0.0784	CbGeAlD
Dexrazoxane—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00544	0.00609	CcSEcCtD
Dexrazoxane—Injection site reaction—Docetaxel—head and neck cancer	0.0054	0.00605	CcSEcCtD
Dexrazoxane—Haemoglobin—Hydroxyurea—head and neck cancer	0.00528	0.00591	CcSEcCtD
Dexrazoxane—Haemorrhage—Hydroxyurea—head and neck cancer	0.00525	0.00588	CcSEcCtD
Dexrazoxane—Alopecia—Vinblastine—head and neck cancer	0.00509	0.0057	CcSEcCtD
Dexrazoxane—TOP2B—thyroid gland—head and neck cancer	0.00498	0.0712	CbGeAlD
Dexrazoxane—Oesophagitis—Docetaxel—head and neck cancer	0.00497	0.00556	CcSEcCtD
Dexrazoxane—Angiopathy—Hydroxyurea—head and neck cancer	0.00477	0.00534	CcSEcCtD
Dexrazoxane—Dysphagia—Fluorouracil—head and neck cancer	0.00473	0.00529	CcSEcCtD
Dexrazoxane—Sepsis—Docetaxel—head and neck cancer	0.00472	0.00528	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Vinblastine—head and neck cancer	0.00465	0.00521	CcSEcCtD
Dexrazoxane—Alopecia—Hydroxyurea—head and neck cancer	0.00464	0.0052	CcSEcCtD
Dexrazoxane—Anaemia—Vinblastine—head and neck cancer	0.00464	0.00519	CcSEcCtD
Dexrazoxane—Phlebitis—Docetaxel—head and neck cancer	0.00458	0.00513	CcSEcCtD
Dexrazoxane—Erythema—Hydroxyurea—head and neck cancer	0.00457	0.00512	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00454	0.00508	CcSEcCtD
Dexrazoxane—Malaise—Vinblastine—head and neck cancer	0.00452	0.00506	CcSEcCtD
Dexrazoxane—Leukopenia—Vinblastine—head and neck cancer	0.00449	0.00503	CcSEcCtD
Dexrazoxane—Pancytopenia—Fluorouracil—head and neck cancer	0.00449	0.00502	CcSEcCtD
Dexrazoxane—TOP2B—head—head and neck cancer	0.00442	0.0631	CbGeAlD
Dexrazoxane—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00435	0.00487	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00424	0.00475	CcSEcCtD
Dexrazoxane—Pneumonia—Fluorouracil—head and neck cancer	0.00424	0.00474	CcSEcCtD
Dexrazoxane—Anaemia—Hydroxyurea—head and neck cancer	0.00423	0.00473	CcSEcCtD
Dexrazoxane—Discomfort—Vinblastine—head and neck cancer	0.00422	0.00472	CcSEcCtD
Dexrazoxane—Infestation—Fluorouracil—head and neck cancer	0.00421	0.00472	CcSEcCtD
Dexrazoxane—Infestation NOS—Fluorouracil—head and neck cancer	0.00421	0.00472	CcSEcCtD
Dexrazoxane—Malaise—Hydroxyurea—head and neck cancer	0.00413	0.00462	CcSEcCtD
Dexrazoxane—Stomatitis—Fluorouracil—head and neck cancer	0.00411	0.0046	CcSEcCtD
Dexrazoxane—Leukopenia—Hydroxyurea—head and neck cancer	0.00409	0.00458	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Vinblastine—head and neck cancer	0.00401	0.00449	CcSEcCtD
Dexrazoxane—Hyponatraemia—Docetaxel—head and neck cancer	0.00396	0.00444	CcSEcCtD
Dexrazoxane—Agranulocytosis—Fluorouracil—head and neck cancer	0.00393	0.0044	CcSEcCtD
Dexrazoxane—Anorexia—Vinblastine—head and neck cancer	0.0039	0.00437	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00387	0.00433	CcSEcCtD
Dexrazoxane—Discomfort—Hydroxyurea—head and neck cancer	0.00385	0.00431	CcSEcCtD
Dexrazoxane—Haemoglobin—Fluorouracil—head and neck cancer	0.0038	0.00426	CcSEcCtD
Dexrazoxane—Haemorrhage—Fluorouracil—head and neck cancer	0.00378	0.00423	CcSEcCtD
Dexrazoxane—Infection—Hydroxyurea—head and neck cancer	0.00371	0.00415	CcSEcCtD
Dexrazoxane—TOP2A—thyroid gland—head and neck cancer	0.00366	0.0523	CbGeAlD
Dexrazoxane—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00366	0.0041	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00366	0.00409	CcSEcCtD
Dexrazoxane—Skin disorder—Hydroxyurea—head and neck cancer	0.00363	0.00406	CcSEcCtD
Dexrazoxane—Breast disorder—Docetaxel—head and neck cancer	0.00357	0.00399	CcSEcCtD
Dexrazoxane—Anorexia—Hydroxyurea—head and neck cancer	0.00356	0.00398	CcSEcCtD
Dexrazoxane—Decreased appetite—Vinblastine—head and neck cancer	0.00356	0.00398	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00355	0.00398	CcSEcCtD
Dexrazoxane—Constipation—Vinblastine—head and neck cancer	0.0035	0.00392	CcSEcCtD
Dexrazoxane—Pain—Vinblastine—head and neck cancer	0.0035	0.00392	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00348	0.0039	CcSEcCtD
Dexrazoxane—Dysphagia—Docetaxel—head and neck cancer	0.00341	0.00382	CcSEcCtD
Dexrazoxane—Feeling abnormal—Vinblastine—head and neck cancer	0.00337	0.00378	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00335	0.00375	CcSEcCtD
Dexrazoxane—Alopecia—Fluorouracil—head and neck cancer	0.00334	0.00374	CcSEcCtD
Dexrazoxane—Dyspnoea—Hydroxyurea—head and neck cancer	0.00333	0.00373	CcSEcCtD
Dexrazoxane—Somnolence—Hydroxyurea—head and neck cancer	0.00332	0.00372	CcSEcCtD
Dexrazoxane—Erythema—Fluorouracil—head and neck cancer	0.00329	0.00369	CcSEcCtD
Dexrazoxane—Decreased appetite—Hydroxyurea—head and neck cancer	0.00325	0.00363	CcSEcCtD
Dexrazoxane—Pancytopenia—Docetaxel—head and neck cancer	0.00324	0.00363	CcSEcCtD
Dexrazoxane—Abdominal pain—Vinblastine—head and neck cancer	0.00324	0.00362	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00322	0.00361	CcSEcCtD
Dexrazoxane—Fatigue—Hydroxyurea—head and neck cancer	0.00322	0.0036	CcSEcCtD
Dexrazoxane—Constipation—Hydroxyurea—head and neck cancer	0.00319	0.00357	CcSEcCtD
Dexrazoxane—Pain—Hydroxyurea—head and neck cancer	0.00319	0.00357	CcSEcCtD
Dexrazoxane—Neutropenia—Docetaxel—head and neck cancer	0.00319	0.00357	CcSEcCtD
Dexrazoxane—TOP2B—lymph node—head and neck cancer	0.00309	0.0442	CbGeAlD
Dexrazoxane—Weight decreased—Docetaxel—head and neck cancer	0.00309	0.00345	CcSEcCtD
Dexrazoxane—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00308	0.00344	CcSEcCtD
Dexrazoxane—Pneumonia—Docetaxel—head and neck cancer	0.00306	0.00342	CcSEcCtD
Dexrazoxane—Anaemia—Fluorouracil—head and neck cancer	0.00304	0.00341	CcSEcCtD
Dexrazoxane—Infestation NOS—Docetaxel—head and neck cancer	0.00304	0.0034	CcSEcCtD
Dexrazoxane—Infestation—Docetaxel—head and neck cancer	0.00304	0.0034	CcSEcCtD
Dexrazoxane—Stomatitis—Docetaxel—head and neck cancer	0.00296	0.00332	CcSEcCtD
Dexrazoxane—Body temperature increased—Hydroxyurea—head and neck cancer	0.00295	0.0033	CcSEcCtD
Dexrazoxane—Leukopenia—Fluorouracil—head and neck cancer	0.00295	0.0033	CcSEcCtD
Dexrazoxane—Asthenia—Vinblastine—head and neck cancer	0.00294	0.00329	CcSEcCtD
Dexrazoxane—Agranulocytosis—Docetaxel—head and neck cancer	0.00284	0.00318	CcSEcCtD
Dexrazoxane—Myalgia—Fluorouracil—head and neck cancer	0.0028	0.00314	CcSEcCtD
Dexrazoxane—Diarrhoea—Vinblastine—head and neck cancer	0.0028	0.00314	CcSEcCtD
Dexrazoxane—Discomfort—Fluorouracil—head and neck cancer	0.00277	0.0031	CcSEcCtD
Dexrazoxane—Haemoglobin—Docetaxel—head and neck cancer	0.00274	0.00307	CcSEcCtD
Dexrazoxane—Haemorrhage—Docetaxel—head and neck cancer	0.00273	0.00306	CcSEcCtD
Dexrazoxane—Dizziness—Vinblastine—head and neck cancer	0.00271	0.00303	CcSEcCtD
Dexrazoxane—Oedema peripheral—Docetaxel—head and neck cancer	0.00269	0.00301	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Docetaxel—head and neck cancer	0.00268	0.003	CcSEcCtD
Dexrazoxane—Asthenia—Hydroxyurea—head and neck cancer	0.00268	0.003	CcSEcCtD
Dexrazoxane—Infection—Fluorouracil—head and neck cancer	0.00267	0.00299	CcSEcCtD
Dexrazoxane—Nervous system disorder—Fluorouracil—head and neck cancer	0.00264	0.00295	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00263	0.00295	CcSEcCtD
Dexrazoxane—Vomiting—Vinblastine—head and neck cancer	0.0026	0.00291	CcSEcCtD
Dexrazoxane—Headache—Vinblastine—head and neck cancer	0.00256	0.00287	CcSEcCtD
Dexrazoxane—Anorexia—Fluorouracil—head and neck cancer	0.00256	0.00287	CcSEcCtD
Dexrazoxane—Diarrhoea—Hydroxyurea—head and neck cancer	0.00255	0.00286	CcSEcCtD
Dexrazoxane—Cardiac disorder—Docetaxel—head and neck cancer	0.00253	0.00284	CcSEcCtD
Dexrazoxane—Angiopathy—Docetaxel—head and neck cancer	0.00248	0.00277	CcSEcCtD
Dexrazoxane—Dizziness—Hydroxyurea—head and neck cancer	0.00247	0.00276	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Docetaxel—head and neck cancer	0.00246	0.00275	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00245	0.00274	CcSEcCtD
Dexrazoxane—Nausea—Vinblastine—head and neck cancer	0.00243	0.00272	CcSEcCtD
Dexrazoxane—Insomnia—Fluorouracil—head and neck cancer	0.00243	0.00272	CcSEcCtD
Dexrazoxane—Alopecia—Docetaxel—head and neck cancer	0.00241	0.0027	CcSEcCtD
Dexrazoxane—Dyspnoea—Fluorouracil—head and neck cancer	0.0024	0.00268	CcSEcCtD
Dexrazoxane—Mental disorder—Docetaxel—head and neck cancer	0.00239	0.00268	CcSEcCtD
Dexrazoxane—Somnolence—Fluorouracil—head and neck cancer	0.00239	0.00267	CcSEcCtD
Dexrazoxane—Erythema—Docetaxel—head and neck cancer	0.00238	0.00266	CcSEcCtD
Dexrazoxane—Malnutrition—Docetaxel—head and neck cancer	0.00238	0.00266	CcSEcCtD
Dexrazoxane—Vomiting—Hydroxyurea—head and neck cancer	0.00237	0.00266	CcSEcCtD
Dexrazoxane—Headache—Hydroxyurea—head and neck cancer	0.00234	0.00262	CcSEcCtD
Dexrazoxane—Decreased appetite—Fluorouracil—head and neck cancer	0.00234	0.00262	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00232	0.0026	CcSEcCtD
Dexrazoxane—Pain—Fluorouracil—head and neck cancer	0.0023	0.00257	CcSEcCtD
Dexrazoxane—TOP2A—lymph node—head and neck cancer	0.00227	0.0325	CbGeAlD
Dexrazoxane—Nausea—Hydroxyurea—head and neck cancer	0.00222	0.00248	CcSEcCtD
Dexrazoxane—Feeling abnormal—Fluorouracil—head and neck cancer	0.00221	0.00248	CcSEcCtD
Dexrazoxane—Anaemia—Docetaxel—head and neck cancer	0.0022	0.00246	CcSEcCtD
Dexrazoxane—Urticaria—Fluorouracil—head and neck cancer	0.00213	0.00239	CcSEcCtD
Dexrazoxane—Syncope—Docetaxel—head and neck cancer	0.00213	0.00239	CcSEcCtD
Dexrazoxane—Leukopenia—Docetaxel—head and neck cancer	0.00213	0.00238	CcSEcCtD
Dexrazoxane—Body temperature increased—Fluorouracil—head and neck cancer	0.00212	0.00238	CcSEcCtD
Dexrazoxane—Loss of consciousness—Docetaxel—head and neck cancer	0.00209	0.00234	CcSEcCtD
Dexrazoxane—Cough—Docetaxel—head and neck cancer	0.00207	0.00232	CcSEcCtD
Dexrazoxane—Myalgia—Docetaxel—head and neck cancer	0.00202	0.00227	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00201	0.00225	CcSEcCtD
Dexrazoxane—Dry mouth—Docetaxel—head and neck cancer	0.00198	0.00222	CcSEcCtD
Dexrazoxane—Infection—Docetaxel—head and neck cancer	0.00193	0.00216	CcSEcCtD
Dexrazoxane—Shock—Docetaxel—head and neck cancer	0.00191	0.00214	CcSEcCtD
Dexrazoxane—Nervous system disorder—Docetaxel—head and neck cancer	0.0019	0.00213	CcSEcCtD
Dexrazoxane—Pruritus—Fluorouracil—head and neck cancer	0.0019	0.00213	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Docetaxel—head and neck cancer	0.0019	0.00213	CcSEcCtD
Dexrazoxane—Skin disorder—Docetaxel—head and neck cancer	0.00188	0.00211	CcSEcCtD
Dexrazoxane—Anorexia—Docetaxel—head and neck cancer	0.00185	0.00207	CcSEcCtD
Dexrazoxane—Diarrhoea—Fluorouracil—head and neck cancer	0.00184	0.00206	CcSEcCtD
Dexrazoxane—Dizziness—Fluorouracil—head and neck cancer	0.00178	0.00199	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00177	0.00198	CcSEcCtD
Dexrazoxane—Insomnia—Docetaxel—head and neck cancer	0.00175	0.00196	CcSEcCtD
Dexrazoxane—Dyspnoea—Docetaxel—head and neck cancer	0.00173	0.00194	CcSEcCtD
Dexrazoxane—Somnolence—Docetaxel—head and neck cancer	0.00172	0.00193	CcSEcCtD
Dexrazoxane—Vomiting—Fluorouracil—head and neck cancer	0.00171	0.00191	CcSEcCtD
Dexrazoxane—Decreased appetite—Docetaxel—head and neck cancer	0.00169	0.00189	CcSEcCtD
Dexrazoxane—Headache—Fluorouracil—head and neck cancer	0.00168	0.00188	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00167	0.00187	CcSEcCtD
Dexrazoxane—Fatigue—Docetaxel—head and neck cancer	0.00167	0.00187	CcSEcCtD
Dexrazoxane—Constipation—Docetaxel—head and neck cancer	0.00166	0.00186	CcSEcCtD
Dexrazoxane—Pain—Docetaxel—head and neck cancer	0.00166	0.00186	CcSEcCtD
Dexrazoxane—Feeling abnormal—Docetaxel—head and neck cancer	0.0016	0.00179	CcSEcCtD
Dexrazoxane—Nausea—Fluorouracil—head and neck cancer	0.0016	0.00179	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00159	0.00178	CcSEcCtD
Dexrazoxane—Body temperature increased—Docetaxel—head and neck cancer	0.00153	0.00172	CcSEcCtD
Dexrazoxane—Abdominal pain—Docetaxel—head and neck cancer	0.00153	0.00172	CcSEcCtD
Dexrazoxane—Asthenia—Docetaxel—head and neck cancer	0.00139	0.00156	CcSEcCtD
Dexrazoxane—Pruritus—Docetaxel—head and neck cancer	0.00137	0.00154	CcSEcCtD
Dexrazoxane—Diarrhoea—Docetaxel—head and neck cancer	0.00133	0.00149	CcSEcCtD
Dexrazoxane—Dizziness—Docetaxel—head and neck cancer	0.00128	0.00144	CcSEcCtD
Dexrazoxane—Vomiting—Docetaxel—head and neck cancer	0.00123	0.00138	CcSEcCtD
Dexrazoxane—Headache—Docetaxel—head and neck cancer	0.00122	0.00136	CcSEcCtD
Dexrazoxane—Nausea—Docetaxel—head and neck cancer	0.00115	0.00129	CcSEcCtD
